90 related articles for article (PubMed ID: 1283860)
1. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone.
Teale DM; Atkinson AM
J Antimicrob Chemother; 1992 Dec; 30(6):839-42. PubMed ID: 1283860
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitric oxide synthase in experimental gram-negative sepsis.
Evans T; Carpenter A; Silva A; Cohen J
J Infect Dis; 1994 Feb; 169(2):343-9. PubMed ID: 7508968
[TBL] [Abstract][Full Text] [Related]
3. The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia.
Henderson JL; Statman R; Cunningham JN; Cheng W; Damiani P; Siconolfi A; Horovitz JH
Arch Surg; 1994 Dec; 129(12):1271-4; discussion 1275. PubMed ID: 7527209
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
Lui SF; Cheng AB; Leung CB; Wong KC; Li PK; Lai KN
Am J Nephrol; 1994; 14(3):182-6. PubMed ID: 7977477
[TBL] [Abstract][Full Text] [Related]
5. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy.
Bonatti H; Guggenbichler JP; Hager J
Infection; 1990; 18(5):302-6. PubMed ID: 2276826
[TBL] [Abstract][Full Text] [Related]
6. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
Midy D; Pometan JP; Baste JC; Pajadon V
J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
[TBL] [Abstract][Full Text] [Related]
8. Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
Kanellakopoulou K; Giamarellou H; Papadothomakos P; Tsipras H; Chloroyiannis J; Theakou R; Sfikakis P
Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):449-53. PubMed ID: 8359165
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
Janvier G; Carles J
Ann Chir; 1993; 47(4):370-5. PubMed ID: 8352517
[TBL] [Abstract][Full Text] [Related]
10. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhibition of nitric oxide synthesis on TNF alpha serum levels in E. coli endotoxemic rats.
Boczkowski J; Philip I; Tedgui A; Bernard C; Merval R; Desmonts JM; Aubier M
Life Sci; 1995; 57(13):PL147-52. PubMed ID: 7545771
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
Finkel MS; Oddis CV; Mayer OH; Hattler BG; Simmons RL
J Pharmacol Exp Ther; 1995 Feb; 272(2):945-52. PubMed ID: 7531767
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin in the treatment of CAPD peritonitis.
De Vecchi AF
Am J Nephrol; 1995; 15(2):180. PubMed ID: 7733161
[No Abstract] [Full Text] [Related]
14. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
Bedarida GV; Kim D; Blaschke TF; Hoffman BB
Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
[TBL] [Abstract][Full Text] [Related]
15. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
Reif DW; McCreedy SA
Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.
Martínez-Florensa M; Consuegra-Fernández M; Aranda F; Armiger-Borràs N; Di Scala M; Carrasco E; Pachón J; Vila J; González-Aseguinolaza G; Lozano F
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27895015
[TBL] [Abstract][Full Text] [Related]
17. Use of imipenem-cilastatin in pediatrics.
Overturf GD
Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
[No Abstract] [Full Text] [Related]
18. Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Au E; Tow A; Allen DM; Ang PT
Ann Acad Med Singap; 1994 Nov; 23(6):819-22. PubMed ID: 7741492
[TBL] [Abstract][Full Text] [Related]
19. Beneficial herb-drug interaction of rhein in Jinhongtang and Imipenem/Cilastatin mediated by organic anion transporters.
Wu F; Zhao T; Zhang Y; Wang Y; Liao G; Zhang B; Wang C; Tian X; Feng L; Fang B; Huo X; Ma X
J Ethnopharmacol; 2023 Aug; 312():116449. PubMed ID: 37023835
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
